ABOUT UNIVO
Unifying Patients and Research for the Benefit of All
Every protocol represents a person. That’s why Univo IRB’s mission is to unify patients and research through ethical review that ensures participants have a voice and clinical trials move forward confidently.
Univo IRB provides independent institutional review board (IRB) and research ethics board (REB) services throughout the United States and Canada, including:
- IRB and REB initial review and continuing oversight
- Central and single site review models
- Institutional biosafety committee (IBC) review
- Regulatory guidance and consulting
- Research compliance training
We support sponsors, CROs, and research sites with efficient, transparent review aligned with U.S. regulations, ICH GCP E6 R3, and Canadian standards, including TCPS2 and applicable provincial requirements. Through our OneVerse® platform, we offer responsive communication, practical guidance, and greater visibility, delivering an agile, reliable IRB experience that reduces uncertainty and simplifies the path to approval.
Backed by our dedicated customer service, proven regulatory experience, and unwavering commitment to patient advocacy, we do more than review research. We support it, strengthen it, and help bring new therapies to patients with speed, clarity, and confidence.
FEATURED ARTICLES
-
![Medical team, tablet, meeting-GettyImages-2177971058]( "Real-World Evidence Revisited")
Explore how the latest regulatory updates transform real-world data into a credible evidentiary pathway. Learn the new standards for data reliability and hybrid study design.
-
![GettyImages-2200850893-US-FDA-Food-Drug-Administration]( "General Wellness Isn't A Vibe Anymore: What The 2026 FDA Update Means")
The FDA’s 2026 guidance has put an end to "wellness by disclaimer." Learn how new standards for wearables and apps impact study design, participant safety, and the evolving ethical role of the IRB.
-
![coding, application development, software-GettyImages-2012746930]( "Clinical Decision Support Software: Clear Expectations For Research Oversight")
The FDA’s 2026 CDS guidance signals a shift to settled policy. IRBs must now demand greater transparency regarding automation bias and clinician independence to accurately assess study risk.
-
![GettyImages-1551861554-FDA]( "The FDA's Final BIMO \"Processes And Practices\" Guidance")
Gain a clear roadmap for investigators, sponsors, and IRBs. This shift toward transparency replaces regulatory guesswork with predictable standards for every partner in the research ecosystem.
-
![GettyImages-1245953899 IRB compliance]( "What Does The FDA's 2025 Safety Reporting Guidance Mean For You?")
New FDA guidance aligns IND safety reports with unanticipated problems, shifting the focus from administrative definitions to proactive participant protection and trial integrity.
-
![business contract signing-GettyImages-1223604108]( "Clinical Research Update: The New FDA Form 1572 is Available")
Stay current with the latest FDA investigator filing updates. Learn when to transition to the new version and how to maintain compliance without unnecessary administrative re-work.
-
![Global health safety regulation-GettyImages-2245658628]( "FDA Updates Guidance For Written IRB Policies")
Explore how updated FDA and HHS guidance harmonizes regulations, streamlines IRB operations, and strengthens oversight for complex clinical trials.
CONTACT INFORMATION
Univo IRB
4509 Creedmoor Road, Suite 403
Raleigh, NC 27612
UNITED STATES
FEATURED SOLUTIONS
-
![GettyImages-1759287088 patient nurse consultation]( "Eliminate Review Friction With An Industry-First IRB Platform")
Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
-
![GettyImages-1282633951-laptop-man-suit-office-quality-management]( "A Fast, Friendly, Fair IRB Designed For Modern Research Sites")
Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
-
![GettyImages-2161842577-business-professional-laptop-office-table]( "Overcome Biosafety Challenges With An Innovative IBC")
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
![Training GettyImages-1366428092]( "Good Clinical Practice Training That Goes Beyond The Basics")
Strengthen trial compliance and data integrity by mastering GCP through practical, real-world scenarios designed to prevent costly errors and ensure audit readiness across your research team.
